Kawasaki disease: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
No edit summary
 
(67 intermediate revisions by 16 users not shown)
Line 1: Line 1:
__NOTOC__
{{Kawasaki disease}}
{| class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right;"
|-
| {{#ev:youtube|https://https://www.youtube.com/watch?v=sTyDHTUCw48|350}}
|-
|}
{{DiseaseDisorder infobox |
{{DiseaseDisorder infobox |
   Name          = Kawasaki disease |
   Name          = Kawasaki disease |
Line 9: Line 16:
   OMIM_mult      = |
   OMIM_mult      = |
   MedlinePlus    = 000989 |
   MedlinePlus    = 000989 |
  eMedicineSubj  = med |
  eMedicineTopic = 1223 |
   eMedicineSubj  = ped |
   eMedicineSubj  = ped |
   eMedicineTopic = 1236 |
   eMedicineTopic = 1236 |
Line 16: Line 21:
   MeshID        = D009080 |
   MeshID        = D009080 |
}}
}}
{{Search infobox}}
'''For patient information, click [[Kawasaki disease (patient information)|here]]'''
{{WikiDoc Cardiology Network Infobox}}
{{CMG}}


'''Associate Editor-In-Chief:''' {{CZ}}
{{CMG}}; {{AE}} {{SH}}, {{AKK}}


{{SK}} Mucocutaneous lymph node syndrome; Lymph node syndrome; Acute febrile vasculitic syndrome
===[[The Heart in Kawasaki Disease | For the heart in Kawasaki disease click here]]===


==[[Kawasaki disease overview|Overview]]==


===[[The Heart in Kawasaki Disease | for the heart in Kawasaki disease click here]]===
==[[Kawasaki disease historical perspective|Historical Perspective]]==


'''Kawasaki disease''', also known as '''lymph node syndrome''', '''mucocutaneous node disease''', '''infantile polyarteritis''' and '''Kawasaki syndrome''', is a poorly understood self-limited [[vasculitis]] that affects many organs, including the [[skin]] and [[mucous membrane]]s, [[lymph node]]s, [[blood vessel]] walls, and the [[heart]]. It does not seem to be contagious. It was first described in 1967 by Dr. Tomisaku Kawasaki in Japan.<ref>{{cite journal | author = Kawasaki T | title = [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children] | format=in Japanese | journal = Arerugi | volume = 16 | issue = 3 | pages = 178-222 | year = 1967 | id = PMID 6062087}}</ref>
==[[Kawasaki disease classification|Classification]]==


== Epidemiology and Demographics ==
==[[Kawasaki disease pathophysiology|Pathophysiology]]==
KS occurs worldwide, with the highest incidence in Japan, and it most often affects boys and younger children. KS may have a winter-spring seasonality, and community-wide outbreaks have been reported occasionally. In the continental United States, population-based and hospitalization studies have estimated an incidence of KS ranging from 9 to 19 per 100,000 children younger than 5 years of age. Approximately 4248 hospitalizations for KS, of which 3277 (77%) were for children under 5 years of age, were estimated among children younger than 18 years of age in the United States in the year 2000.


CDC uses hospital discharge data, a passive KS surveillance system, and special studies to describe the incidence and epidemiology of KS in the United States. The KS surveillance system has been maintained by CDC since 1976 and is based on voluntary reporting of KS cases by health care providers and local and state health authorities. A standardized case report form is used to collect information on patients.
==[[Kawasaki disease causes|Causes]]==


For epidemiologic surveillance, CDC defines a case of KS as illness in a patient with fever of 5 or more days duration (or fever until the date of administration of intravenous immunoglobulin if it is given before the fifth day of fever), and the presence of at least 4 of the following 5 clinical signs:
==[[Kawasaki disease differential diagnosis|Differentiating Kawasaki disease from other Diseases]]==


*Rash
==[[Kawasaki disease epidemiology and demographics|Epidemiology and Demographics]]==
*Cervical lymphadenopathy (at least 1.5 cm in diameter)
*Bilateral conjuctival injection
*Oral mucosal changes
*Peripheral extremity changes.


Patients whose illness does not meet the above KS case definition but who have fever and coronary artery abnormalities are classified as having atypical or incomplete KS.
==[[Kawasaki disease risk factors|Risk Factors]]==


==Incidence, causes, and risk factors==
==[[Kawasaki disease screening|Screening]]==
By far, the highest incidence of Kawasaki disease occurs in Japan (175 per 100,000), though its incidence in the United States is increasing. Kawasaki disease is predominantly a disease of young children, with 80% of patients younger than 5 years of age. Additional risk factors in the United States include Asian race and male sex.


The causative agent of Kawasaki disease is still unknown. However, current [[etiology|etiological]] theories center primarily on [[immune system|immunological]] causes for the disease. Much research is being performed to discover a definitive [[toxin]] or [[antigen]]ic substance, possibly a [[superantigen]], that is the specific cause of the disease. An unknown virus may play a role as an inciting factor as well.
==[[Kawasaki disease natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 
The [[cardiac]] complications are, by far, the most important aspect of the disease. Kawasaki disease can cause vasculitic changes (inflammation of blood vessels) in the [[coronary arteries]] and subsequent '''coronary artery [[aneurysm]]s'''. These aneurysms can lead to [[myocardial infarction]] ([[myocardial infarction|heart attack]]) even in young children. Overall, about 10&ndash;18% of children with Kawasaki disease develop coronary artery aneurysms<ref>{{cite journal | author = Belay E, Maddox R, Holman R, Curns A, Ballah K, Schonberger L | title = Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. | journal = Pediatr Infect Dis J | volume = 25 | issue = 3 | pages = 245-9 | year = 2006 | id = PMID 16511388}}</ref>, with much higher prevalence among patients who are not treated early in the course of illness.  Kawasaki disease is the most common cause of acquired heart disease among children in the United States.
 
==Symptoms==
Kawasaki disease often begins with a high and persistent [[fever]] that is not very responsive to normal doses of [[acetaminophen]] or [[ibuprofen]]. The fever may persist steadily for up to two weeks and is normally accompanied by irritability. Affected children develop red eyes, red [[mucous membrane]]s in the mouth, red cracked lips, a "[[strawberry tongue]]", iritis, keratic precipitates (detectable by an ophthalmologist but usually too small to be seen by the unaided eye), and swollen [[lymph node]]s. [[Skin rash]]es occur early in the disease, and peeling of the skin in the [[genital area]], hands, and feet (especially around the nails and on the palms and soles) may occur in later phases. Some of these symptoms may come and go during the course of the illness. If left untreated, the symptoms will eventually relent, but coronary artery aneurysms will not improve, resulting in a significant risk of death or disability due to myocardial infarction (heart attack).  If treated in a timely fashion, this risk can be mostly avoided and the course of illness cut short.
 
* High-grade fever (greater than 39&nbsp;°C or 102&nbsp;°F; often as high as 40&nbsp;°C  or 104&nbsp;°F) that normally lasts for more than a week if left untreated.
* Red eyes ([[conjunctivitis]]) without pus or drainage, also known as "conjunctival injection"
* Bright red, chapped, or cracked lips
* Red [[mucous membrane]]s in the mouth
* Strawberry tongue, white coating on the tongue or prominent red bumps ([[papillae]]) on the back of the tongue
* Red palms of the hands and the soles of the feet
* Swollen hands and feet
* Rash which may take many forms, but not vesicular (blister-like), on the trunk
* Swollen [[lymph node]]s (frequently only one lymph node is swollen), particularly in the neck area
* Joint pain ([[arthralgia]]) and swelling, frequently symmetrical
* Irritability
* [[Tachycardia]] (rapid heart beat)
* Peeling (desquamation) palms and soles (later in the illness); peeling may begin around the nails
 
==Signs and tests==
A physical examination will demonstrate many of the features listed above.
 
Blood tests
* [[Complete blood count]] (CBC) may reveal normocytic [[anemia]] and eventually [[thrombocytosis]]
* [[Erythrocyte sedimentation rate]] (ESR) will be elevated
* [[C-reactive protein]] (CRP) will be elevated
* [[Liver function tests]] may show evidence of hepatic inflammation and low [[serum albumin]]
 
Other tests (may or may not be performed)
* [[Electrocardiogram]] may show evidence of [[ventricular]] dysfunction or, occasionally, [[arrhythmia]] due to [[myocarditis]]
* [[Echocardiogram]] may show subtle coronary artery changes or, later, true aneurysms.
* [[Ultrasound]] or [[computerized tomography]] may show hydrops (enlargement) of the [[gallbladder]]
* [[Urinalysis]] may show white blood cells and protein in the urine ([[pyuria]] and [[proteinuria]]) without evidence of bacterial growth
* [[Lumbar puncture]] may show evidence of [[aseptic meningitis]]
* [[Angiography]] was historically used to detect coronary artery aneurysms and remains the gold standard for their detection, but is rarely used today unless coronary artery aneurysms have already been detected by echocardiography.


==Diagnosis==
==Diagnosis==
Kawasaki disease is diagnosed clinically (by [[medical sign]]s and [[symptom]]s), and there exists no specific laboratory test that can tell if someone has it. It is normally difficult to establish the diagnosis, especially early in the course of illness, and frequently children are not diagnosed until they have seen their doctor several times, or visited a number of different health care providers. Many other serious illnesses can cause similar symptoms, and must be considered in the [[differential diagnosis]], including [[scarlet fever]], [[toxic shock]] syndrome, and [[juvenile idiopathic arthritis]].
[[Kawasaki disease diagnostic criteria|Diagnostic criteria]] | [[Kawasaki disease history and symptoms|History and Symptoms]] | [[Kawasaki disease physical examination|Physical Examination]] | [[Kawasaki disease laboratory findings|Laboratory Findings]] | [[Kawasaki disease electrocardiogram|Electrocardiogram]] | [[Kawasaki disease x ray|X-Ray Findings]] | [[Kawasaki disease echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Kawasaki disease CT scan|CT-Scan Findings]] | [[Kawasaki disease MRI|MRI Findings]] | [[Kawasaki disease other imaging findings|Other Imaging Findings]] | [[Kawasaki disease other diagnostic studies|Other Diagnostic Studies]]
 
Classically, five days of fever plus four of five [[diagnostic]] criteria must be met in order to establish the diagnosis.
 
The criteria are:
 
(1) [[erythema]] of the lips or oral cavity or cracking of the lips;
 
(2) rash on the trunk;
 
(3) swelling or erythema of the hands or feet;
 
(4) red eyes (conjunctival injection)
 
(5) swollen lymph node in the neck of at least 15 millimeters.
 
Many children, especially infants, eventually diagnosed with Kawasaki disease do not exhibit all of the above criteria. In fact, many experts now recommend treating for Kawasaki disease even if only three days of fever have passed and at least three diagnostic criteria are present, especially if other tests reveal abnormalities consistent with Kawasaki disease. In addition, the diagnosis can be made purely by the detection of coronary artery aneurysms in the proper clinical setting.


==Treatment==
==Treatment==
Children with Kawasaki disease should be hospitalized and cared for by a physician who has experience with this disease. When in an academic medical center, care is often shared between pediatric [[cardiology]] and pediatric [[infectious disease]] specialists, although no [[infectious agent]] has been demonstrated. It is imperative that treatment be started as soon as the diagnosis is made to prevent damage to the [[coronary arteries]].
[[Kawasaki disease medical therapy|Medical Therapy]] | [[Kawasaki disease surgery|Surgery]] | [[Kawasaki disease primary prevention|Primary Prevention]] [[Kawasaki disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Kawasaki disease future or investigational therapies|Future or Investigational Therapies]]
 
[[Intravenous immunoglobulin]] ([[IVIG]]) is the standard treatment for Kawasaki disease and is administered in high doses with marked improvement usually noted within 24 hours.


[[Salicylate]] therapy, particularly [[aspirin]], remains an important part of the treatment but [[salicylate]]s alone are not as effective as [[Intravenous immunoglobulin]]. Aspirin therapy is started at high doses until the fever subsides, and then is continued at a low dose when the patient returns home. Except for Kawasaki disease and a couple of other indications, aspirin is otherwise normally not recommended for children due to its association with [[Reye's syndrome]].
==Case Studies==
 
[[Kawasaki disease case study one|Case #1]]
[[Corticosteroids]] have also been used, especially when other treatments fail or symptoms recur, but in a randomized controlled trial, the addition of corticosteroid to immune globulin and aspirin did not improve outcome. <ref>Newburger JW et al, Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease, N Engl J Med. 2007 Feb 25;356(7):663-75</ref>
 
The are also treatments for iritis and other eye symptoms.
 
==Prognosis==
With early treatment, rapid recovery from the acute symptoms can be expected and the risk of coronary artery aneurysms greatly reduced.  Untreated, the acute symptoms of Kawasaki disease are self-limited (''i.e.'' the patient will recover eventually), but the risk of coronary artery involvement is much greater. Overall, about 2% of patients die from complications of coronary vasculitis. Patients who have had Kawasaki disease should have an [[echocardiogram]] initially every few weeks, and then every 1&ndash;2 years to screen for progression of cardiac involvement.
 
It is also not uncommon that a [[relapse]] of symptoms may occur soon after initial treatment with [[IVIG]]. This usually requires re-hospitalization and retreatment. Treatment with [[IVIG]] can cause allergic and non-allergic acute reactions, aseptic meningitis, [[fluid overload]] and, rarely, other serious reactions. Aspirin may increase the risk of bleeding from other causes and may be associated with Reye's syndrome. Overall, life-threatening complications resulting from therapy for Kawasaki disease are exceedingly rare, especially compared with the risk of non-treatment.
 
==Media==
Kawasaki disease was mentioned in the television programs Nip/Tuck and Without a Trace <ref>Episode 86 (4x16) - The Little Things (2 March, 2006)</ref>.  In the episode All In of the TV series House, it was inexplicably mentioned as a possible diagnosis for a 6 year old boy that was admitted with bloody diarrhea and coordination problems, as well as an elderly woman with unexplained respiratory, cardiovascular and neural deficiencies. Maxie Jones, a fictional character on General Hospital suffers from it. According to John Travolta and Kelly Preston, their son Jett Travolta also suffers from the disease.
 
==References==
{{Reflist|2}}


[[Category: (name of the system)]]
==External links==
==External links==
*[http://www.kdfoundation.org/ Kawasaki Disease Foundation]
*[http://www.kdfoundation.org/ Kawasaki Disease Foundation]
Line 137: Line 70:
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Rheumatology]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 14:35, 24 April 2018

Kawasaki disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Kawasaki disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kawasaki disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kawasaki disease

CDC on Kawasaki disease

Kawasaki disease in the news

Blogs on Kawasaki disease

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Kawasaki disease

https://https://www.youtube.com/watch?v=sTyDHTUCw48%7C350}}

Template:DiseaseDisorder infobox For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2], Arzu Kalayci, M.D. [3]

Synonyms and keywords: Mucocutaneous lymph node syndrome; Lymph node syndrome; Acute febrile vasculitic syndrome

For the heart in Kawasaki disease click here

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Kawasaki disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

External links

Template:Diseases of the musculoskeletal system and connective tissue


Template:WikiDoc Sources

de:Kawasaki-Syndrom it:Sindrome di Kawasaki he:מחלת קווסקי nl:Ziekte van Kawasaki th:โรคคาวาซากิ